US FDA explains medtech benefit-risk evaluation and design considerations for pivotal trials
This article was originally published in RAJ Devices
Executive Summary
The US Food and Drug Administration is seeking feedback on two draft guidance documents relating to the pre-market review of medical devices. The first guidance explains the factors the FDA considers when making benefit-risk determinations in pre-market reviews, and the second guidance sets out design considerations for pivotal clinical investigations1,2.